INTRODUCTION
The biofilm-degrading enzymes DNase I, α-amylase and dispersin B (DspB) reduced the EPS 145 mass and biofilm cell numbers (62-65). However, the older the P. aeruginosa biofilm, the more 
180
Despite the high cost of production, biofilm eradicating enzymes could possibly be used as an 181 alternative or as a synergistic helper to antibiotics in treatments of persistent infections. 
182

QUORUM SENSING INHIBITORS: STOP TALKING, HELP KILLING
183
Quorum sensing (QS) regulates virulence behaviors, including biofilm formation (76). QS
192
Recently, inhibition of QS and biofilm formation had been reported in several studies 80). 
MECHANISMS OF ACTION IN ASSISTING ANTIBIOTICS
242
Essential oils (EOs) are natural antimicrobial formulations with broad-spectrum activity against Overall, the antimicrobial potential of NPs compounds may depend on their sizes, charges and 305 stability in order to enhance antibiotics and control biofilm. However, the safe consumption of
306
NPs must be established before using them in pharmaceutical formulation as antibacterial agents.
307
CONCLUSION: COMPLEMENTARY APPROACH MAY BE A SOLUTION THAT
308
WORKS WITHOUT ABANDONING 'OLD-TIMER' ANTIBIOTICS
309
In this mini-review, the attempt was made to bring the reader'sattention to the mentioned Finding an effective strategy to control biofilm formation remains a challenge (Table 1) . • Some EOs produce oxidative stress and possess toxic properties inducing killing activity against eukaryotes (141).
• Increased albumin level and skin irritation (see review of Patel [141] • High stability in the biological environment and high carrier capacity.
• The possibility to incorporate both hydrophilic and hydrophobic molecules.
• Its viability using different courses (oral, parenteral and inhaled) of administration.  Design nanoparticles (NPs) to ensure release of an efficient drug concentration from the matrix (139).

The antimicrobial potential of NPs depends on size, charge, stability and biocompatibility (116).  Cytotoxicity (142). 
